申请人:INSTITUT NATIONAL DE LA SANTE ET DE LA
RECHERCHE MEDICALE (INSERM)
公开号:EP1411041A1
公开(公告)日:2004-04-21
The present invention concerns a 4-hydroxy-2E-alkenoic acid according to formula (I) below
in which R is chosen in the group consisting of CH3-, CH3-(CH2)3- and CH3-(CH2)3-CH=CH- and its use as lipid peroxidation marker. The present invention also concerns methods to determine its presence and its level in solution and methods for the diagnosis of a pathology involving an increase in lipid peroxidation and for following the effectiveness of the treatment of said pathologies.
本发明涉及一种根据下式(I)的4-羟基-2E-烯酸
其中R选自CH3-、CH3-(CH2)3-和CH3-(CH2)3-CH=CH-的群组,并且其用作脂质过氧化标记物。本发明还涉及确定其在溶液中的存在和水平的方法,以及用于诊断涉及脂质过氧化增加的病理的方法,以及用于跟踪治疗所述病理的有效性的方法。